ImmunoPrecise Antibodies Ltd. filed its 40-F on Jul 10, 2023 for the period ending Apr 30, 2023. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | 0.00% | +2.40% | -25.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.15% | 33.68M | |
-3.64% | 89.33B | |
+4.08% | 41.19B | |
-15.09% | 31.87B | |
+53.68% | 24.52B | |
-15.13% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.08% | 8.28B |
- Stock Market
- Equities
- IPA Stock
- News ImmunoPrecise Antibodies Ltd.
- ImmunoPrecise Antibodies Ltd. Auditor Raises 'Going Concern' Doubt